ZIVERI, Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 1.512
EU - Europa 1.257
AS - Asia 548
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 3.330
Nazione #
US - Stati Uniti d'America 1.471
CN - Cina 377
FI - Finlandia 300
IE - Irlanda 265
SE - Svezia 233
UA - Ucraina 185
DE - Germania 161
SG - Singapore 101
IT - Italia 62
TR - Turchia 50
CA - Canada 41
GB - Regno Unito 26
IN - India 17
BE - Belgio 10
NL - Olanda 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 3
AU - Australia 2
BG - Bulgaria 1
ES - Italia 1
PL - Polonia 1
Totale 3.330
Città #
Dublin 265
Jacksonville 236
Chandler 229
Dearborn 166
Ashburn 108
Nanjing 79
Boardman 72
Singapore 72
Beijing 70
San Mateo 61
Ann Arbor 60
Princeton 57
Shanghai 52
Izmir 49
Toronto 37
Wilmington 37
Bremen 31
Helsinki 26
New York 26
Nanchang 23
Woodbridge 16
Hefei 15
Jiaxing 15
Kunming 15
Seattle 15
Shenyang 13
Parma 12
Changsha 11
Des Moines 11
Brussels 10
Santa Clara 10
Auburn Hills 9
Fremont 8
Guangzhou 8
Jinan 8
Abidjan 6
Düsseldorf 6
Hebei 6
Norwalk 6
Brno 5
Dallas 5
Tianjin 5
Chengdu 4
Frankfurt am Main 4
Grafing 4
Houston 4
Los Angeles 4
Mestre 4
Munich 4
Naples 4
Zhengzhou 4
Amsterdam 3
Chicago 3
Leawood 3
Ningbo 3
Palermo 3
Pune 3
Southend 3
Andover 2
Borås 2
Genoa 2
Hangzhou 2
Lanzhou 2
Monmouth Junction 2
Padova 2
Rockville 2
Taizhou 2
Anzano Di Puglia 1
Ardabil 1
Augusta 1
Bangalore 1
Brisbane 1
Centro 1
Cervignano Del Friuli 1
Changchun 1
Chongqing 1
Fucecchio 1
Fuzhou 1
Haikou 1
Huizen 1
Islington 1
Kocaeli 1
Las Vegas 1
Laurel 1
London 1
Madison 1
Madrid 1
Mahestan 1
Milan 1
Mountain View 1
Nanning 1
Ottawa 1
Portland 1
Rancho Cucamonga 1
Redmond 1
Rieti 1
Salerno 1
San Diego 1
San Francisco 1
Shaoxing 1
Totale 2.079
Nome #
Insulin sensitivity in obese children: which clinical and biochemical parameters are useful in clinical practice? 87
Insulin production and resistance in cystic fibrosis: Effect of age, disease activity, and genotype 85
IL-6, IGFBP-1 ed IGFBP-2 (mRNA e proteine) sono aumentati nella placenta e nel siero cordonale di neonati IUGR: una nuova ipotesi per il deficit accrescitivo 85
Insulin sensitivity,adiponectin and resistin are related with the inflammatory status and pulmonary function in cystic fibrosis (CF) 84
Effects if Interlukin (IL)-1b on proliferation, differentiation ans apoptosis in vitro in Caco-2 cells are mediated by the IL-1 receptor type I only in the un-differentiated state 83
Effects of cord serum Insulin, IGF-II, IGFBP-2, IL-6 and Cortisol concentrations on human Birth Weight and Lenght: Pilot Study 83
Modificazioni e rapporti di IGF-1, IL-6, TNF-alfa, adiponectina e resistina con markers di sensibilità insulinica nella fibrosi cistica 82
Rapporti fra citochine infiammatorie e fattori di crescita: meccanismi noti ed ipotizzabili negli IUGR 80
Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and gluten-free diet. 80
Street ME, Seghini P, Fieni S, Viveri MA, Viani I, Martorana D, Volta C, Neri T M, Granellini D, Bernasconi S 78
New insights into glucose metabolism in cystic fibrosis (CF) 77
Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. 75
IL-6 and IGFBP-2 Are increased in IUGR,and greater in symmetric (early onset)IUGR both in the placenta and cord serum 71
CO-14 ALTERAZIONE DEL SEGNALE INSULINICO IN CELLULE EPITELIALI BRONCHIALI DI FIBROSI CISTICA 71
IL-6, IGFBP-1, IGFBP-2 (mRNA and proteins) and IGF-II are significantly increased in the placenta and correlate with neonatal size in IUGR with altered placental doppler velocimetry 70
Thyroid function,cytokine and IGF-IGFBP interactions in cystic fibrosis patients 68
INTERAZIONI E RAPPORTI TRA SISTEMA IGF, IL-6, TNF-ALFA , TSH E SENSIBILITA' INSULINICA IN SOGGETTI OBESI PREPUBERI 65
Spontaneous growth hormone (GH) secretion is not directly affected by Ghrelin in either short normal prepubertal children or in children with neurosecretory dysfunction 64
Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with foetal growth. 64
Clinical use and significance of determinants of insulin sensitivity in obese children 63
Interazione tra Leptina e Cortisolo, GH e TSH 63
ESPE/LWPES 7th joint meeting Paediatric Endocrinology, Lyon, France, Sept 21-24 62
Fattori di crescita e citochine nella placenta e nel neonato SGA. 61
IL-6,IGF-1,IGF-II,IGFBP-I and IGFBP-2 gene expression and corresponding protein changes in the placenta but not in cord serum during the third trimester of gestation 60
Interleukin-6 and Insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation 59
Differences in insulin-like growth factor (IGF)-I,IGF binding proteins(BP),and interleukin-6 (IL-6)levels,in thyroid desease versus controls, 59
The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis. 58
Changes in Interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. 57
Differences in insulin-like growth factor (IGF)-I, IGF-binding proteins (BP), and interleukin-6 (IL-6) levels, in thyroid disease versus controls 56
Relationship between urinary concentrations of phthalate metabolites and waist circumference, Body Mass Index, and insulin-resistance in obese children 55
Insulin receptor signal transduction is impaired in placentas of intra-uterine growth restricted (IUGR) newborns 55
Placental adiponectin concentration is significntly decreased in IUGR subjects and is related with head circumference at birth 55
Inflammatory markers asociated with anthropometric and metabolic variables in pre-pubertal children 55
INSULIN RECEPTOR SIGNAL TRANSDUCTIO IS IMPAIRED IN PLACENTAL OF INTRA-UTERINE GROWTH RESTRICTED (IUGR) NEWBORNS 54
Interleukin (IL-6)and IGF-binding protein (BP)interactions from in vitro data to inflammatory bowel desease (IBD)and cystic fibrosis (CF)patients. 53
Inflammation is a modulator of the Insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioctivity of IGFs in cystic fibrosis 53
Nuovo approccio allo studio delle interazioni tra Il-6 e sistema IGF-IGFBP nella placenta e nel siero cordonale di nati IUGR. Confronto fra risultati statistici e delle Reti Neuronali Artificiali 52
MARKERS DI SENSIBILITA' INSULINICA E TRADUZIONE DEL SEGNALE INSULINICO IN PLACENTE DI NATI IUGR RISPETTO A NATI APPROPRIATI PER L'ETA' GESTAZIONALE (AGA) E CORRELAZIONI CON I PARAMETRI AUXOLOGICI ALLA NASCITA 52
Differences in insulin, cortisol, insulin receptor activation, resistin and their relationships with IL-6 in intrauterine growth restriction (IUGR) and control placentas and cord serum 51
High Mobility Group Box-1 Serum Concentrations Increase at Onset of Diabetes in Cystic Fibrosis Patients 51
Significant increase in IL-6, IGFBP-1 and IGFBP-2 in the placenta and cord serum of IUGR newborns: a possible explanation for impaired growth 49
Interactions of leptin and thyrotropin 24-hour secretory profiles in short-normal children. 48
Interazioni tra IL-6, TNF-alfa, e sistema IGF e loro effetti sull'accrescimento statruro-ponderale in pazienti prepuberi affetti da fibrosi cistica 48
Rapporti tra citochine infiammatorie, IGFBP-2, crescita e dieta priva di glutine nei 12 mesi successivi alla diagnosi di celiachia 47
Spontaneous 24-hour Ghrelin secretion in short-normal prepuberal children 46
Iteractions of Leptin andThyrotropin 24-Hours Secretory Profiles in Short Normal Children 45
Inflammatory gene polymorphisms-relation to obesity, metabolic and pro-inflammatory markers in Bulgarian pre- pubertal children 45
Spontaneous GH secretion is not directly affected by ghrelin either in short-normal prepuberal children or in children with GH neurosecretory dysfunction. 44
Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet 44
Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease 41
Markers of insulin sensitivity in placentas and cord serum of intrauterine growth restricted (IUGR) newborns. 40
In Cystic Fibrosis thyroid function is normal and independent of inflammatory status and growth factors serum levels 39
Interleukin (IL)-1b and IL-6 decrease IGFBP-2 secretion in intestinal cells and increase IGFBP-2 serum levels in CROHN’S disease (CD) and ulcerative colitis (UC) 37
Insulin-like growth factor binding protein-2 and IGF-II are related to interleukin-6 and not to tumor necrosis factor - serum levels in cystic fibrosis patients 36
Serum IL-6, TNF-a and IGFBP-2 are increased at diagnosis of Coeliac Disease (CD) and normalise on gluten-free diet while height velocity increases 32
Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: Pilot study 32
Livelli sierici basali e dopo stimolazione della gastrina G 17 nei bambini. 31
Totale 3.340
Categoria #
all - tutte 12.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020500 0 0 0 19 67 112 111 24 56 43 9 59
2020/2021317 0 44 36 0 53 1 40 2 70 6 64 1
2021/2022273 3 2 1 8 9 9 30 50 8 27 54 72
2022/2023960 108 107 68 49 97 112 5 52 317 3 30 12
2023/2024325 14 10 4 7 26 72 20 76 6 4 36 50
2024/2025161 15 65 65 16 0 0 0 0 0 0 0 0
Totale 3.340